Sign in
4

Changes in Ownership

KYNTRA BIO, INC. Filed Acc 0001209191-21-015013

Chief Commercial Officer acquired 16,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Wettig Thane · Chief Commercial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2021-02-24 Grant or award : show line 1 in the form +16,500 47,150 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-02-24 Grant or award : show line 2 in the form Stock Option (Right to Buy) +32,100 32,100 D
Loading xslF345X03/doc4.xml…